Literature DB >> 410576

Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).

M Rashid, A Khairi, C Johnston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 410576

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  8 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

2.  Short term high doses of etidronate in Paget's disease of bone.

Authors:  J A Kanis; R E Gray; S A Murray; N A Hamdy; G H Urwin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

3.  [Osteitis deformans (Paget)--or a tarda-type of a hereditary hyperphosphatasia (author's transl)].

Authors:  A Enderle; S von Gumppenberg
Journal:  Arch Orthop Trauma Surg       Date:  1979-07-31

4.  Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).

Authors:  K S Eyres; P Marshall; E McCloskey; D L Douglas; J A Kanis
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

5.  Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonate.

Authors:  M Audran; P Clochon; D Etghen; B Mazieres; J C Renier
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

6.  Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.

Authors:  Avraam Avramidis; Stergios A Polyzos; Efstratios Moralidis; Georgios Arsos; Zoe Efstathiadou; Konstantinos Karakatsanis; Georgios Grollios; Marina Kita
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

7.  Focal mineralization defect during disodium etidronate treatment of calcinosis.

Authors:  R S Weinstein
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

8.  Problem fracture in Paget's disease of bone.

Authors:  R E Gray; E A Jenkins; M A Hall; M Swann; B M Ansell
Journal:  J R Soc Med       Date:  1989-10       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.